Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1

Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1

The clinical heterogeneity of prostate cancer (PCa) makes it difficult to identify those patients that could benefit from more aggressive treatments. As a contribution to a better understanding of the genomic changes in the primary tumor that are associated with the development of high-risk disease,...

Full description

Bibliographic Details
Main Authors: Spans, Lien, Van den Broeck, Thomas, Smeets, Elien, Prekovic, Stefan, Thienpont, Bernard, Lambrechts, Diether, Karnes, R. Jeffrey, Erho, Nicholas, Alshalalfa, Mohammed, Davicioni, Elai, Helsen, Christine, Gevaert, Thomas, Tosco, Lorenzo, Haustermans, Karin, Lerut, Evelyne, Joniau, Steven, Claessens, Frank
Format: Online
Language:English
Published: Impact Journals LLC 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029704/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029704/

Similar Items